Introduction {#Sec1}
============

Isoprenylated flavonoids are a group of natural products with diverse structures and important bioactivities. A large number of new compounds have been isolated mainly from species of the Leguminosae, Moraceae, and Euphorbiaceae families, and some of the compounds showed antibacterial, antioxidant, anti-HIV, antidiabetic, and tyrosinase-inhibiting effects \[[@CR1]\]. The genus *Macaranga* Thou. (Euphorbiaceae) comprises about 300 species mainly distributed in the tropical regions of Africa, Asia, Australia, and the Pacific islands \[[@CR2]\]. The leaves of some *Macaranga* species have been used as folk medicine for the treatment of swellings, cuts, sores, boils, and bruises \[[@CR3]\]. *Macaranga denticulata* (Bl.) Muell. Arg. is a tree with rich resources in Hainan and Xishuangbanna areas of China. Its roots have been used as traditional Chinese medicine against icteric hepatitis, eczema, and epigastric pain \[[@CR4]\]. Previous phytochemical studies on this plant resulted in the isolation of isoprenylated flavonoids and diterpenylated flavonoids or stilbenes, some of which showed antioxidant, acetylcholinesterase-inhibiting, and antiangiogenic activities \[[@CR5]--[@CR7]\].

Protein tyrosine phosphatase 1B (PTP1B) has been regarded as a promising target for treating type 2 diabetes and obesity \[[@CR8]\]. Discovery of effective PTP1B inhibitors is one of our research interests \[[@CR9]--[@CR12]\], and a few of isoprenylated phenolics including flavonoids and Diels--Alder adducts were found to have significant PTP1B inhibitory effects \[[@CR9], [@CR10]\]. In our continuing search for natural PTP1B inhibitors from plants, chemical investigations of *M. denticulata* were carried out. Fractionation of the ethanol extract afforded nine isoprenylated flavonoids, including three new C-methylated and isoprenylated chalcones, dentichalcones A--C (**1--3**), together with six known compounds, (2*E*)-1-(5,7-dihydroxy-2,2,6-trimethyl-*2H*-benzopyran-8-yl)-3-(4-methoxyphenyl)-2-propen-1-one (**4**), (2*E*)-1-(5,7-dihydroxy-2,2-dimethyl-2*H*-benzopyran-8-yl)-3-phenyl-2-propen-1-one (**5**), laxichalcone (**6**), macarangin (**7**), bonanniol A (**8**), and bonannione A (**9**) (Fig. [1](#Fig1){ref-type="fig"}). The isolated compounds were tested in vitro for inhibition on PTP1B enzymatic activity. Compounds **4**--**9** showed significant inhibitory effects. This is the first report of C-methylated and isoprenylated chalcones from the genus *Macaranga*. Herein, we describe the structural elucidation and biological evaluation of these compounds.Fig. 1Structures of compounds **1--9**

Results and Discussion {#Sec2}
======================

Dentichalcone A (**1**) was assigned the molecular formula C~21~H~20~O~5~ by HREIMS with an *m/z* 352.1308 \[M\]^+^ (calcd for C~21~H~20~O~5~, 352.1311). The IR spectrum showed absorptions for OH (3417 cm^−1^), carbonyl (1625 cm^−1^), and aromatic (1605, 1514, and 1445 cm^−1^) moieties. The ^1^H NMR spectrum (Table [1](#Tab1){ref-type="table"}) displayed a hydrogen-bonded hydroxyl signal at *δ*~H~ 14.62 (1H, s, OH-2′), two *trans*-coupled olefinic protons at *δ*~H~ 8.08 (1H, d, *J* = 15.6 Hz, H-α) and 7.76 (1H, d, *J* = 15.6 Hz, H-β), resonances of a 1,4-disubstituted benzene moiety at *δ*~H~ 7.61 (2H, d, *J* = 8.6 Hz, H-2, 6) and 6.95 (2H, d, *J* = 8.6 Hz, H-3, 5), a methyl group at *δ*~H~ 2.05 (3H, s, H~3~-7′), and signals of a 2,2-dimethylpyran ring at *δ*~H~ 6.70 (1H, d, *J* = 10.0 Hz, H-1″), 5.59 (1H, d, *J* = 10.0 Hz, H-2″), and 1.56 (6H, s, H~3~-4″, 5″). The ^13^C NMR spectrum (Table [1](#Tab1){ref-type="table"}) exhibited 21 carbon signals: three methyls, eight *sp*^2^ methines, and ten quaternary carbons including a carbonyl, eight *sp*^2^, and one oxygenated *sp*^3^. These NMR spectroscopic data indicated that **1** was a chalcone derivative with an isoprenoid and a C-methyl group. By interpretation of the HMBC and NOESY spectra (Fig. [2](#Fig2){ref-type="fig"}), the structure of **1** was established. The HMBC cross-peaks of H-α/C-γ, C-1 and H-β/C-α, C-γ, C-1, C-6 verified the presence of chalcone skeleton. The hydroxyl group at *δ*~H~ 14.62 were assigned to OH-2′ by the HMBC correlations of OH-2′/C-1′, C-2′, C-3′. The methyl group at *δ*~H~ 2.05 (H~3~-7′) was located at C-3′ by the HMBC correlations of H~3~-7′/C-2′, C-3′, C-4′. The 2,2-dimethylpyran group was fused at C-5′ and C-6′, as deduced from the HMBC correlations of H-1″/C-4′, C-5′, C-6′ and H-2″/C-5′, together with the key NOESY correlations of H~3~-4″, 5″/H-α and H-2, 6. Thus, the structure of **1** was elucidated as (2*E*)-1-(5,7-dihydroxy-2,2,6-trimethyl-2*H*-benzopyran-8-yl)-3-(4-hydroxyphenyl)-2- propen-1-one and named dentichalcone A.Table 1^1^H and ^13^C NMR spectroscopic data of compounds **1**--**3** (in acetone-*d* ~6~)Position**1** ^a^**2** ^a^**3** ^a^*δ* ~C~*δ* ~H~ (*J* in Hz)*δ* ~C~*δ* ~H~ (*J* in Hz)*δ* ~C~*δ* ~H~ (*J* in Hz)1128.0133.2136.72, 6131.17.61, d (8.6)130.07.10, d (8.3)129.77.86, br d (7.3)3, 5116.96.95, d (8.6)116.06.75, d (8.3)129.57.44, m4160.7156.4130.87.44, mα125.18.08, d (15.6)46.63.40, t (7.6)129.08.54, d (15.5)β143.47.76, d (15.6)30.42.89, t (7.6)142.77.75, d (15.5)γ193.5207.3194.01′106.4105.9106.42′165.4164.4165.53′104.4104.2104.44′158.2158.0158.65′103.2102.9103.36′154.9155.4155.07′7.82.05, s^b^7.72.05, s^b^7.82.06, s^b^1″117.86.70, d (10.0)117.66.65, d (10.0)119.76.79, d (10.0)2″125.85.59, d (10.0)125.85.53, d (10.0)122.55.52, d (10.0)3″78.278.381.54″27.81.56, s27.71.44, s66.53.90, d (11.9)\
3.61, d (11.9)5″27.81.56, s27.71.44, s22.71.57, sOH-2′14.62, s14.10, s14.52, s^a^Data were measured at 400 MHz (^1^H) and 100 MHz (^13^C)^b^Signals are overlappedFig. 2Selected HMBC and NOESY correlations of compounds **1--3**

Dentichalcone B (**2**) was assigned the molecular formula C~21~H~22~O~5~ by HREIMS (*m/z* 354.1465 \[M\]^+^; calcd for C~21~H~22~O~5~, 354.1467). Comparison of its NMR spectroscopic data (Table [1](#Tab1){ref-type="table"}) with those of **1** showed that **2** was a dihydrochalcone derivative of **1**. This was confirmed by some diagnostic signals at *δ*~H~ 3.40 (2H, t, *J* = 7.6 Hz, H~2~-α) and 2.89 (2H, t, *J* = 7.6 Hz, H~2~-β) and at *δ*~C~ 46.6 (C-α), and 30.4 (C-β), and 207.3 (C-γ) and by the HMBC correlations of H~2~-α/C-γ, C-1 and H~2~-β/C-α, C-γ, C-1, C-6 (Fig. [2](#Fig2){ref-type="fig"}). Thus, the structure of **2** was elucidated as 1-(5,7-dihydroxy-2,2,6-trimethyl-2*H*-benzopyran-8-yl)-3-(4-hydroxyphenyl)propan-1-one and named dentichalcone B.

Dentichalcone C (**3**) was assigned the molecular formula C~21~H~20~O~5~ by HRESIMS (*m/z* 351.1237 \[M--H\]^−^; calcd for C~21~H~19~O~5~, 351.1238). The ^1^H and ^13^C NMR spectra indicated the presence of a chalcone skeleton with a hydrogen-bonded hydroxyl and a methyl group, which was similar to that of **1**. Its NMR spectra also displayed signals of a monosubstituted benzene ring \[*δ*~H~ 7.86 (2H, br d, *J* = 7.3 Hz, H-2, 6), 7.44 (3H, m, H-3, 4, 5); *δ*~C~ 136.7 (C-1), 130.8 (C-4), 129.7 (C-2, 6), and 129.5 (C-3, 5)\] and resonances of a 2-hydroxymethyl-2-methylpyran moiety \[*δ*~H~ 6.79 (1H, d, *J* = 10.0 Hz, H-1″), 5.52 (1H, d, *J* = 10.0 Hz, H-2″), 3.90 and 3.61 (each 1H, d, *J* = 11.9 Hz, H-4″a, b), 1.57 (3H, s, H~3~-5″); *δ*~C~ 119.7 (C-1″), 122.5 (C-2″), 81.5 (C-3″), 66.5 (C-4″), 22.7 (C-5″)\]. The planar structure of **3** was further constructed by the HMBC spectrum (Fig. [2](#Fig2){ref-type="fig"}). The stereochemistry at C-3″ could not be assigned by the available data. Thus, the structure of **3** was elucidated as (2*E*)-1-\[5,7-dihydroxy-2-(hydroxymethyl)-2,6-dimethyl-2*H*-benzopyran-8-yl\]-3-phenyl-2-propen-1-one and named dentichalcone C.

The known compounds were identified as (2*E*)-1-(5,7-dihydroxy-2,2,6-trimethyl-*2H*-benzopyran-8-yl)-3-(4-methoxyphenyl)-2-propen-1-one (**4**) \[[@CR13]\], (2*E*)-1-(5,7-dihydroxy-2,2-dimethyl-2*H*-benzopyran-8-yl)-3-phenyl-2-propen-1-one (**5**) \[[@CR14]\], laxichalcone (**6**) \[[@CR15]\], macarangin (**7**) \[[@CR7]\], bonanniol A (**8**) \[[@CR16]\], and bonannione A (**9**) \[[@CR16]\] (Fig. [1](#Fig1){ref-type="fig"}) by comparison of their spectroscopic data with those reported. Compound **4** was a new natural product, which was previously reported as a synthetic molecule \[[@CR13]\].

All the isolated compounds were tested in vitro for the inhibitory effects on PTP1B. Compounds **4**--**9** showed inhibition with IC~50~ values ranging from 14.0 ± 1.2 to 48.8 ± 5.5 μM (Table [2](#Tab2){ref-type="table"}). Oleanolic acid, an effective natural PTP1B inhibitor \[[@CR17]\], was used as the positive control (IC~50~ = 2.6 ± 0.6 μM).Table 2Inhibitory activities of compounds **4**--**9** against PTP1BCompoundIC~50~ ± SD (µM)**4**48.8 ± 5.5**5**19.3 ± 1.4**6**20.7 ± 5.3**7**22.7 ± 4.6**8**15.2 ± 2.8**9**14.0 ± 1.2Oleanolic acid2.6 ± 0.6

In summary, this is the first report of C-methylated and isoprenylated chalcones from the genus *Macaranga*. This class of compounds is distributed limitedly in the family Euphorbiaceae, and only *Mallotus philippinensis* was reported to produce C-methylated or both C-methylated and isoprenylated chalcones \[[@CR18]--[@CR21]\]. The *Macaranga* and *Mallotus* genera are monophyletic sister groups in the family Euphorbiaceae, which show a remarkable resemblance in their phylogeny, habit, and geographical distribution \[[@CR22]\]. The present study indicates that the two genera also have some similarity in their secondary metabolites. Furthermore, isoprenylated flavonoids as potent PTP1B inhibitors for the therapy of obesity and type 2 diabetes need further studies.

Experimental Section {#Sec3}
====================

General Experimental Procedures {#Sec4}
-------------------------------

Optical rotation was measured on a JASCO P-1030 digital polarimeter. UV spectra were recorded on a Hitachi U-2900 spectrophotometer. IR spectra were measured on a Nicolet Avatar-360 spectrometer with KBr pellets. NMR spectra were obtained on Varian Mercucy Plus 400 instruments. Chemical shifts were reported with TMS as internal standard or with respect to acetone-*d*~6~ (*δ*~H~ 2.04, *δ*~C~ 206.0 ppm). EIMS (70 eV) and HREIMS were recorded on an Agilent 5973N and a Waters Micromass GCT mass spectrometer, respectively. ESIMS and HRESIMS were performed on an Agilent 1100 LC/MSD and a Bruker Daltonics ApexIII mass spectrometer, respectively. Semi-preparative HPLC was performed on an Agilent 1200 (Agilent Technologies, Palo Alto, CA, USA) and a Sepax Amethyst C18 column (150 × 10 mm, 5 μm, Sepax Techologies, Inc., Newark, DE, USA), using a UV detector set at 210 nm. Column chromatography (CC) was performed on silica gel (200-300 mesh, Yantai Institute of Chemical Technology, Yantai, People's Republic of China), Diaion HP-20 (Mitsubishi Chemical Co., Tokyo, Japan), and Sephadex LH-20 gel (GE Healthcare Amersham Biosciences, Uppsala, Sweden). Fractions were monitored by TLC analysis run on precoated silica gel GF254 plates (10--40 μm, Yantai Institute of Chemical Technology, Yantai, People's Republic of China).

Plant Material {#Sec5}
--------------

The twigs and leaves of *M. denticulata* were collected in Hekou County, Yunnan Province, People's Republic of China, in April 2011. The plant material was identified by Dr. Qin-Shi Zhao, Kunming Institute of Botany, Chinese Academy of Sciences, and a voucher specimen (TCM 11-04-15 Hou) has been deposited at the Herbarium of the Department of Pharmacognosy, School of Pharmacy, Fudan University.

Extraction and Isolation {#Sec6}
------------------------

The milled, air-dried twigs and leaves of *M. denticulata* (5.0 kg) were percolated with 95 % EtOH at room temperature (60 L). The filtrate was evaporated under reduced pressure to give a residue (500 g), which was suspended in H~2~O and extracted with CH~2~Cl~2~ (4 × 1 L). The CH~2~Cl~2~ extract (140 g) was subjected to CC on Diaion HP-20 eluted with 90 % EtOH. The 90 % EtOH fraction (95 g) was separated by CC on silica gel eluted with a gradient of petroleum ether--EtOAc (1:0, 10:1, 5:1, 1:1, 1:2) to give fractions A--J. Fraction D was separated by CC on Sephadex LH-20 eluted with CHCl~3~--MeOH (1:1) to afford fractions D1--D4. Fraction D4 was chromatographed over silica gel eluted with a gradient of petroleum ether--Me~2~CO (10:1, 5:1) to afford fractions D4.1--D4.5. Fraction D4.3 was purified on a Sephadex LH-20 column eluted with MeOH to provide **4** (100 mg). Fraction E was chromatographed by silica gel eluted with a gradient of CH~2~Cl~2~--Me~2~CO (40:1, 2:1) to afford fractions E1--E8. Fraction E4 was separated on silica gel eluted with a gradient of petroleum ether--Me~2~CO (12:1, 10:1) to give fractions E4.1--E4.5. Fraction E4.5 was chromatographed by semi-preparative HPLC (CH~3~OH--H~2~O, 90:10, flow rate 1 mL/min) to afford **6** (10 mg). Fraction F was isolated by CC over Sephadex LH-20 eluted with CHCl~3~--MeOH (1:1) to afford fractions F1--F5. Fractions F2 and F4 were chromatographed over silica gel eluted with a gradient of petroleum ether--EtOAc (10:1, 2:1) to afford fractions F2.1--F2.6 and F4.1--F4.4, respectively. Fractions F2.2, F2.4, and F4.4 were purified by semi-preparative HPLC at flow rate 1 mL/min to afford **2** (4 mg; CH~3~OH--H~2~O, 83:17), **9** (10 mg; CH~3~OH--H~2~O, 90:10), and **7** (12 mg; CH~3~OH--H~2~O, 91:9), respectively. Fraction F4.2 was separated by CC on Sephadex LH-20 eluted with CH~3~OH to provide **1** (15 mg). Fraction G was separated by CC on silica gel eluted with a gradient of CH~2~Cl~2~--Me~2~CO (30:1, 2:1) to give fractions G1--G7. Fractions G2, G3, and G4 were chromatographed by semi-preparative HPLC at flow rate 1 mL/min to yield **5** (2 mg; CH~3~OH--H~2~O, 88:12), **3** (3 mg; CH~3~OH--H~2~O, 80:20), and **8** (12 mg; CH~3~OH--H~2~O, 88:12), respectively.

Dentichalcone A (**1**) {#Sec7}
-----------------------

Red, amorphous powder; UV (MeOH) *λ*~max~ (log ε) 229 (4.43), 244 (4.42) (sh), 289 (4.30), 368 (4.66) nm; IR (KBr) *ν*~max~ 3417, 2972, 2915, 1625, 1605, 1541, 1514, 1445, 1167, 830, 536 cm^−1^; ^1^H NMR and ^13^C NMR data, see Table [1](#Tab1){ref-type="table"}; EIMS *m/z* 352 \[M\]^+^ (30), 337 (64), 217 (100), 91 (15), 77 (7); HREIMS *m/z* 352.1308 \[M\]^+^ (calcd for C~21~H~20~O~5~, 352.1311).

Dentichalcone B (**2**) {#Sec8}
-----------------------

Yellow, amorphous powder; UV (MeOH) *λ*~max~ (log ε) 222 (3.79), 284 (3.82) nm; IR (KBr) *ν*~max~ 3419, 2975, 2924, 1638, 1606, 1515, 1427, 1218, 1165, 1133, 827, 548 cm^−1^; ^1^H NMR and ^13^C NMR data, see Table [1](#Tab1){ref-type="table"}; EIMS *m/z* 354 \[M\]^+^ (49), 339 (100), 233 (35), 219 (33), 191 (36), 107 (47), 91 (16), 77 (21), 65 (8), 43 (8); HREIMS *m/z* 354.1465 \[M\]^+^ (calcd for C~21~H~22~O~5~, 354.1467).

Dentichalcone C (**3**) {#Sec9}
-----------------------

Red, amorphous powder; \[*α*\]~D~^25^−32.9 (*c* 0.30, MeOH); UV (MeOH) *λ*~max~ (log ε) 224 (4.33), 240 (4.26), 287 (4.30), 346 (4.41) nm; IR (KBr) *ν*~max~ 3420, 2975, 2915, 1633, 1595, 1456, 1348, 1171, 1130, 701, 575 cm^−1^; ^1^H NMR and ^13^C NMR data, see Table [1](#Tab1){ref-type="table"}; ESIMS *m/z* 351 \[M--H\]^−^; HRESIMS *m/z* 351.1237 \[M--H\]^−^ (calcd for C~21~H~19~O~5~, 351.1238).

Assay of PTP1B Activity {#Sec10}
-----------------------

The bioassay procedure was the same as that reported previously \[[@CR10], [@CR23]\]. The result of PTP1B inhibition was expressed as IC~50~, which was calculated with Prism 4 software (Graphpad, San Diego, CA).
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